Aspirin for purpura, thrombotic thrombocytopenic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Oct 2022: Trial registered, NCT05568147

The trials

NCT05568147: Aspirin for Prophylaxis of TTP

State
Not started
Phase
Phase 2 and Phase 3
People
100 planned
Started
1 Oct 2022
Primary completion
30 Sep 2027
Arms
Aspirin 100 mg daily
Results
None posted
  1. 5 Oct 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Asa, Aspirin 100mg, Aspirin 100mg for 1-month (immediately after PCI), Aspirin 100mg for 6-month (6-month post PCI), Clopidogrel/acetylsalicylic acid component aspirin, CoPRIME aspirin alone, Duocover component aspirin, Duoplavin component aspirin, Durlaza, Measurin, Yosprala component aspirin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.